Skip to main content

Innovative training network: Immunoprofile-directed stratification of patients with the autoimmune disorder thrombotic thrombocytopenic purpura

Objective

The PROFILE Innovative European Industrial Doctoral programme will develop improved tools for stratification of patients with the autoimmune disorder acquired thrombotic thrombocytopenic purpura (TTP). Patient stratification is needed in order to further develop personalized medicine approaches for human disorders. Therefore, a detailed understanding of the disease at the molecular level is needed. Furthermore, implementation of a robust set of novel biomarkers is essential for stratification of patients. Also, highly flexible platforms to rapidly develop novel therapeutics are crucial to further boost the field of personalized medicine. The research program is embedded in a unique translational training program, which emphasizes clinical needs as a driving force for development of novel, innovative diagnostics and therapeutics (for personalized medicine). There is intersectoral knowledge transfer between academia and companies at the European level as 6 different EU Member states are involved in the network either as beneficiary or partner organization. The PROFILE network will allow 6 early stage researchers to follow this unique translational training. They will be trained in the clinic to identify clinical needs, in academia where they will contribute to a scientifically ambitious project and in the non-academic sector where they will be trained in a novel technologies and commercializing bioassays endowing them with an unique PROFILE for further advancing personalized medicine in Europe.

Call for proposal

H2020-MSCA-ITN-2015
See other projects for this call

Funding Scheme

MSCA-ITN-EID - European Industrial Doctorates

Coordinator

KATHOLIEKE UNIVERSITEIT LEUVEN
Address
Oude Markt 13
3000 Leuven
Belgium
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 501 120

Participants (3)

Stichting Sanquin Bloedvoorziening
Netherlands
EU contribution
€ 510 748,56
Address
Plesmanlaan 125
1006 AN Amsterdam
Activity type
Research Organisations
PROTOBIOS OU
Estonia
EU contribution
€ 226 264,68
Address
Maealuse 4
12618 Tallinn
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
ICOSAGEN AS
Estonia
EU contribution
€ 226 264,68
Address
Nooruse 9
50411 Tartu
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)

Partners (5)

ASSISTANCE PUBLIQUE HOPITAUX DE PARIS
France
Address
3 Avenue Victoria
75000 Paris
Activity type
Research Organisations
Immudex Aps
Denmark
Address
Fruebjergvej 3
2100 Copenhagen
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EUROPEAN HEMATOLOGY ASSOCIATION
Netherlands
Address
Koninginnegracht 12B/13
2514 AA Den Haag
Activity type
Other
Dutch TTP patient organization
Netherlands
Address

Hoogland
Activity type
Other
Biokit
Spain
Address
Can Malé S/n
08186 Lliça D´amunt
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)